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Lung alveolar macrophages (AMs) are in the first line of immune defense against respi-
ratory pathogens and play key roles in the pathogenesis of Mycobacterium tuberculosis 
(Mtb) in humans. Nevertheless, AMs are available only in limited amounts for in  vitro 
studies, which hamper the detailed molecular understanding of host-Mtb interactions 
in these macrophages. The recent establishment of the self-renewing and primary Max 
Planck Institute (MPI) cells, functionally very close to lung AMs, opens unique opportu-
nities for in vitro studies of host-pathogen interactions in respiratory diseases. Here, we 
investigated the suitability of MPI cells as a host cell system for Mtb infection. Bacterial, 
cellular, and innate immune features of MPI cells infected with Mtb were characterized. 
Live bacteria were readily internalized and efficiently replicated in MPI cells, similarly 
to primary murine macrophages and other cell lines. MPI cells were also suitable for 
the determination of anti-tuberculosis (TB) drug activity. The primary innate immune 
response of MPI cells to live Mtb showed significantly higher and earlier induction of the 
pro-inflammatory cytokines TNFα, interleukin 6 (IL-6), IL-1α, and IL-1β, as compared to 
stimulation with heat-killed (HK) bacteria. MPI cells previously showed a lack of induction 
of the anti-inflammatory cytokine IL-10 to a wide range of stimuli, including HK Mtb. 
By contrast, we show here that live Mtb is able to induce significant amounts of IL-10 
in MPI cells. Autophagy experiments using light chain 3B immunostaining, as well as 
LysoTracker labeling of acidic vacuoles, demonstrated that MPI cells efficiently control 
killed Mtb by elimination through phagolysosomes. MPI cells were also able to accumu-
late lipid droplets in their cytoplasm following exposure to lipoproteins. Collectively, this 
study establishes the MPI cells as a relevant, versatile host cell model for TB research, 
allowing a deeper understanding of AMs functions in this pathology.
Keywords: Max Planck institute cells, alveolar macrophages, Mycobacterium tuberculosis, innate response, 
cytokine secretion, autophagy, foamy macrophage
inTrODUcTiOn
Tuberculosis (TB) is a mycobacterial infection generally affecting the lungs. This ancestral disease, 
presents worldwide, affected around 10 million new patients and killed an estimated 1.8 million 
people in 2015 (1), despite the existence of a vaccine and an effective chemotherapy. The emergence 
of drug-resistant strains of Mycobacterium tuberculosis (Mtb), the main causative agent in humans, 
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is an additional concern as it could further increase the risks of 
treatment failure. Host infection occurs when aerosolized, live 
bacteria reach the lower tract of the respiratory system and suc-
cessfully evade innate immunity, usually resulting in the forma-
tion of a granuloma (2, 3). Resident lung alveolar macrophages 
(AMs) are among the first immune cells to encounter invading 
mycobacteria and the outcome of TB disease may be decided by 
the response of these macrophages to the incoming threat (4). 
The responses of AMs to pathogens, including Mtb, are very 
specific and distinct from other macrophages (5). Furthermore, 
entry into macrophages has been linked with metabolic changes 
in mycobacteria, increasing their resistance to antibiotics through 
the activation of efflux (6). Understanding how Mtb and AMs 
interact with each other is thus very important, but the difficulty 
in obtaining AMs in large quantity and in sufficient purity is a 
serious limiting factor. Depending on their origin, development, 
and environmental conditions, macrophages have distinct 
bio logical properties and significant functional differences 
exist among various macrophage populations. Previously, all 
tissue macrophages, including AMs, were believed to be bone 
marrow-derived cells with a limited life span. Recent studies, 
however, demonstrated that most tissue-resident macrophages, 
including AMs, are self-renewing cells of embryonic origin (7, 8). 
The unique characteristics of AMs are tailored by the special 
respiratory microenvironment, where granulocyte macrophage 
colony-stimulating factor (GM-CSF) drives the differentiation of 
AMs from embryonic macrophage precursors and sustains AM 
functions (7, 8).
Recently, a novel cellular model of embryonic derived, self-
renewing tissue-resident macrophages [Max Planck Institute 
(MPI) cells] has been described (9). These GM-CSF dependent, 
primary cells represent an excellent model to study AM functions 
(9–11) but, in contrast to the scarcely available AMs, MPI cells can 
be obtained in virtually unlimited amounts. These very important 
properties could allow the use of these macrophages as a platform 
for high-throughput screening with drugs against Mtb and more 
generally, as a powerful tool for host-pathogen interaction stud-
ies in TB. Immortalized cell lines are routinely used due to their 
availability in large scale, but they often originate from tumors 
and/or were obtained through multiple passages; thus, their 
genetic background is not well defined and their phenotype can 
vary between lots. As such, they may not always be appropriate 
models to understand tissue-specific cellular functions (12, 13), 
or to correctly summarize critical interactions with pathogens, as 
reported in the case of Leishmania (14), adeno-associated virus 
(15), and Mtb (16, 17). In this context, the large-scale availability 
of MPI cells as a primary cellular model mimicking lung AMs 
could open new prospects in the understanding of pulmonary 
diseases, notably those involving complex host-pathogen interac-
tions like TB.
Nevertheless, interactions of live Mtb with MPI cells have not 
been characterized so far. We report here that MPI cells constitute 
a suitable host cell system to study Mtb infection in vitro. This 
pathogen indeed enters and replicates in MPI cells in similar 
patterns as compared to other primary and non-primary cells. 
The innate cytokine response of MPI cells to live and HK Mtb was 
found to be characteristically different. Accordingly, MPI cells 
were able to target dead bacteria for phagolysosomal degradation. 
Altogether, our data show that MPI cells represent a particularly 
attractive and valuable tool for TB research.
MaTerials anD MeThODs
Bacterial culture
Mycobacterium tuberculosis strain H37Rv (ATCC27294) con-
stitutively expressing the green fluorescent protein (GFP) (18), 
referred to as H37Rv-GFP, was grown in 7H9 broth (Invitrogen) 
supplemented with 10% Albumin-Dextrose-Saline, 0.05% Tween 
80 (Sigma-Aldrich), 0.5% glycerol (Invitrogen), and 50  µg/mL 
hygromycin B (Invitrogen). Bacteria were grown for 14 days at 
37°C, 5% CO2 in ventilated Erlenmeyer flasks without shaking, 
with dilution at OD600 nm = 0.1 using fresh medium once a week. 
Bacteria were further grown at 37°C for 2 days with shaking at 
200 rpm, harvested by centrifugation at 3,500 × g for 10 min and 
washed twice with phosphate buffered saline (PBS, Welgene) 
prior to infection. This protocol allowed us to collect well-
individualized bacteria, without clumps.
cell culture
Cells were grown at 37°C, 5% CO2 in RPMI 1640 medium (Welgene) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS, 
Gibco), referred to as RPMI-FBS medium. Raw 264.7 murine 
macrophages were passaged every 2 or 3 days (70% confluence) 
and used between passages 2 and 9. THP-1 human macrophages 
were passaged once a week and differentiated in macrophages 
by 4 days exposure to 50 ng/mL phorbol 12-myristate 13-acetate 
(PMA, Sigma-Aldrich). Murine monocytes were obtained by 
flushing femurs of 6- to 8-week-old Balb/c mice (Orient Bio) 
with RPMI-FBS. Monocytes were differentiated into bone mar-
row-derived macrophages (BMDM) by exposure to 40  ng/mL 
recombinant murine macrophage colony-stimulating fac-
tor (M-CSF, Miltenyi Biotec) for 7  days. A seed stock of MPI 
cells established and characterized earlier (9) was used to 
generate all the MPI cells for this study. Cells from this stock 
were propagated in RPMI-FBS supplemented with 40  ng/mL 
recombinant GM-CSF (Miltenyi Biotec) to quickly increase cell 
density. MPI cells were collected and diluted at a concentration of 
5 × 105 cells/mL twice a week, for 3 weeks. Working stocks were 
prepared from the cells obtained after 6 passages (P6), by freezing 
aliquots of 107 cells in 1 mL of FBS containing dimethyl sulfoxide 
(DMSO) (90:10, v/v) in liquid nitrogen. For each working stock, 
cells were thawed, washed, and grown in 20 mL of RPMI-FBS 
and 40 ng/mL of GM-CSF. MPI cells were further amplified in 
RPMI-FBS and 10 ng/mL GM-CSF and passaged twice a week at 
a concentration of 2 × 105 cells/mL. Cells from passages 8 (P8) 
to 70 (P70) were used.
Mtb infection with Plated cells  
for Microscopy experiments
The day preceding Mtb infection, cells were treated with 1× 
Versene (Gibco) for 10  min at 37°C, gently detached using a 
cell-scraper, centrifuged at 300 × g for 5 min and resuspended 
in fresh RPMI-FBS medium. In the case of MPI cells, culture 
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supernatants were also centrifuged to recover non-attached cells, 
which were pooled together with the scraped cells. Cells were 
enumerated using a Thoma cell counting chamber and suspen-
sions at 5 × 105 cells/mL were prepared. The medium was sup-
plemented with 40 ng/mL M-CSF for BMDM or with 50 ng/mL 
PMA for THP-1 cells. First, 50 μL/well of the cell suspensions 
were distributed in 384-well plates (Greiner, μClear) to reach 
25,000 cells/well. Plates were then incubated overnight at 37°C, 
5% CO2 prior to infection, to allow the cells to attach at the 
bottom of the well. The day of the infection, pellets of freshly 
PBS-washed bacteria were resuspended in RPMI-FBS at the 
required concentration to yield the desired multiplicity of infec-
tion (MOI). For this, bacterial stocks were titrated on 7H11 
agar beforehand, to determine the relationship between optical 
density and bacterial concentration. In our hands, suspensions of 
well-dispersed bacteria at OD600 nm = 1 were reproducibly titrated 
at 1–3 ×  108 bacteria/mL. The medium was removed from the 
plate and 50 μL/well of bacterial suspension were added. For MPI 
cells, plates were also centrifuged at 300 × g for 2 min prior to 
medium removal, to sediment non-adherent cells.
Plates were further incubated for 4 h at 37°C, 5% CO2, then 
centrifuged at 300 × g for 2 min. The medium was removed and 
50 µL/well of fresh RPMI-FBS supplemented with 5 µM Hoechst 
33342 (Sigma-Aldrich) was added. Plates were incubated 20 min 
at 37°C, 5% CO2 before imaging using fluorescence microscopy 
(Operetta, Perkin Elmer). Of importance here, when comparing 
different cell lines together, the same bacterial suspension was 
used for infection, in order to limit variations and allow more 
relevant comparisons.
Quantification of cytokine secretion
Heat-killed (HK) bacteria were prepared by boiling washed bacte-
ria resuspended in PBS (OD600 nm = 1) for 30 min at 95°C. Aliquots 
were prepared and frozen at −80°C until subsequent use. MPI 
cells or BMDM were gathered and enumerated as indicated above 
to prepare suspensions at 5 × 105 cells/mL and plated overnight 
in 24-well plates (Costar, 1 mL/well) at 37°C, 5% CO2. The plates 
were centrifuged at 300 × g for 2 min, the medium removed and 
1 mL/well of bacterial suspension or lipopolysaccharide (LPS) at 
the appropriate concentration was added. At the corresponding 
time points, the plates were centrifuged and the supernatants 
were recovered and sterile-filtered through a 0.22  µm PVDF 
syringe-driven filter (Millex, Millipore). Filte red supernatants 
were stored at −80°C prior to quantification. Cytokines were 
titrated by ELISA, using antibody pairs directed against interleu-
kin 6 (IL-6), TNF-α, IL-1β, IL-10 (ThemoFisher Scientific), and 
IL-1α (Peprotech), following manufacturers’ recommendations. 
All data points were measured in triplicates, and sample con-
centrations were calculated against a standard curve generated 
with recombinant cytokines (ThermoFisher Scientific). Samples 
were tested at different dilutions, ranging from non-diluted to 
50-fold dilutions, to ensure accurate calculation of the cytokine 
concentrations. All experiments were done in triplicates.
Batch infection and isoniazid activity
Isoniazid (INH, Sigma-Aldrich) stock solutions were prepared 
at 1 mM in DMSO (Sigma-Aldrich) and kept at −20°C. Cells 
were gathered and enumerated as indicated above, to prepare 
suspensions at 106  cells/mL. Pellets of freshly PBS-washed 
bacteria were resuspended in RPMI-FBS at the required con-
centrations to yield the desired MOI. One volume of bacterial 
suspension was mixed with one volume of cell and the mixture 
was incubated for 2  h at 37°C with mild shaking (100  rpm). 
Infected cells were washed twice with fresh medium and plated 
at 25,000 cells/well in 384-well plates containing twofold 
dilutions of isoniazid in RPMI-FBS (the dose–response experi-
ments were performed in triplicates). Where required, the final 
volume in each well was adjusted to 50 µL using RPMI-FBS and 
final concentrations of DMSO were kept below 1%. BMDM were 
incubated with 20 ng/mL M-CSF and THP-1 cells with 50 ng/mL 
PMA. After 5  days incubation at 37°C, 5% CO2, 10  µL/well 
of a 30  µM Hoechst 33342 solution in PBS was added (final 
concentration 5 µM) and plates were incubated for 20 min at 
37°C, 5% CO2 before imaging using fluorescence microscopy.
autophagy assessment
Cells were plated overnight, as described above, in 384-well plates 
containing either DMSO (1% final) or chloroquine (Invitrogen, 
50 µM final concentration). Plated cells were infected for 2 h at 
37°C, 5% CO2, then fixed by treatment with 50 μL/well of 10% 
neutral buffered formalin (Sigma-Aldrich) for 30  min at room 
temperature. Cells were washed twice with PBS and permeabi-
lized using 0.2% Triton X-100 (Sigma-Aldrich) in PBS for 15 min 
at room temperature. The medium was removed and a solution 
of light chain 3B (LC3B)-directed rabbit polyclonal antibodies 
(Invitrogen) in PBS (1  µg/mL) was added (50  µL/well). Plates 
were incubated overnight at 4°C and washed three times with 
PBS. A solution of goat anti-rabbit IgG (H  +  L) secondary 
antibodies conjugated with Alexa Fluor 568 probe (Invitrogen) 
was prepared at 5  µg/mL in PBS and incubated with the cells 
(50 µL/well) for 1 h at room temperature. Cells were washed three 
times with PBS and finally stained with 5  µM Hoechst 33342 
solution in PBS (50  µL/well) for 30  min before imaging using 
fluorescence microscopy.
lysoTracker staining
Cells were plated in 384-well plates and infected for 2  h, as 
described above. For infection with formalin-killed bacteria, 
pellets of bacterial culture were resuspended in formalin 
(OD600 nm = 1) and incubated overnight at room temperature. 
Formalin-killed bacteria were washed twice with PBS, resus-
pended in RPMI-FBS at the required MOI, and used similarly 
to live bacteria. After infection, plates were centrifuged at 
300 ×  g for 2  min, the medium was removed, and cells were 
incubated for 2 h with 50 µL/well of 0.5 µM LysoTracker Deep 
Red (Invitrogen) in RPMI-FBS. Cells were stained by addition 
of 10 µL/well of 30 µM Hoechst 33342 in PBS (final concen-
tration 5  µM) for 30  min before imaging using fluorescence 
microscopy.
Preparation of lipid-loaded cells
Cells were plated overnight as described above and medium 
was replaced with 50 µL/well of fresh RPMI-FBS supplemented 
with very low-density lipoproteins (VLDL, Merck Millipore), to 
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reach a final concentration of 140 µg triacylglycerol (TAG) per 
mL of medium (VLDL were usually received at a concentration 
of 9–10  mg TAG/mL). Plates were incubated up to 6  days at 
37°C, 5% CO2 and regularly checked under a light microscope. 
Accumulation of lipid droplets was usually observed 2–4  days 
after exposure to VLDL. At this stage, plates were centrifuged at 
300 × g for 2 min, the medium was removed, and cells were fixed 
by treatment with formalin (50 µL/well) for 30 min at room tem-
perature. Cells were washed twice with PBS and stained with 5 µM 
Hoechst 33342 in PBS (50 µL/well) for 30 min. Cells were washed 
again three times and a 1/100 dilution in PBS of LipidTOX Deep 
Red neutral lipid stain (Invitrogen) was added (50 µL/well). Cells 
were incubated at room temperature for 30 min before imaging 
using fluorescence microscopy.
image acquisition and analysis
Nuclei channel (Hoechst 33342) was obtained using excitation 
(Ex): 405  nm and emission (Em): 450  nm. Bacteria channel 
(GFP) was obtained using Ex: 488  nm; Em: 520  nm. LC3B 
channel (Alexa Fluor 568) was obtained using Ex: 561 nm; Em: 
600 nm. Finally, both lysosome and lipid channels (LysoTracker 
Deep Red and LipidTOX Deep Red) were obtained using Ex: 
640 nm; Em: 690 nm. Color images were obtained through the 
software Harmony v3.5 (Perkin Elmer). At least three fields were 
imaged for each well. For each field, objects (cells, bacteria, and 
vacuoles) were segmented from individual channels using in-
house algorithms, all based on commonly available procedures 
like watershed and threshold-based algorithms. Detected cells 
were counted and split in sub-groups [infected/non-infected 
(NI) bystander cells and/or stained/unstained cells, as appro-
priate]. Ratios of infected/stained cells were calculated as the 
number of infected/stained cells divided by the total number 
of cells. The number of pixels (px) found to be positive for GFP 
signal in the bacterial channel was referred to as the bacterial 
area, expressed in px. For each infected/stained cell, the area 
of intracellular bacteria/stain (in px) was recorded to allow a 
calculation of the average area of intracellular bacteria/stain for 
all the cells in the group, referred to as the bacterial/stain area 
per cell (expressed in px). Values for each field were averaged 
to give a value per well. Values per well were considered to be 
individual replicates (n) and pooled together to plot the graphs 
and determine SD.
statistical analyses
All experiments were repeated with at least three different 
batches of infected cells and showed similar results. Data 
shown are for a representative infection experiment, except for 
Figure 3C, where the number of pooled infections is indicated 
in the legend. For each infection experiment, samples were 
tested at least in triplicates. All graphs were built with Prism 
software v6.0 (GraphPad). The same software was used to 
calculate statistical significance of the differences between the 
indicated data points. A two-way ANOVA with Tukey’s multi-
ple comparisons test was used for Figures 1 and 4, a one-way 
ANOVA with Dunnett’s multiple comparisons test was used 
for Figure 3C, and the unpaired Student’s t-test was used for 
Figures 2 and 5.
resUlTs
adjustment of culture conditions  
for Mtb infection
Under the microscope, MPI cells displayed a homogenous, round 
shape (Figure S1 in Supplementary Material) that was consistent 
with all passages tested (up to P70). The cells grew both attached 
at the surface of the flasks and in suspension. Cells plated in 
384-well plates were easily removed by washings with fresh 
medium, as shown in Figure S2A in Supplementary Material. 
This undesired loss of cells was, however, easily circumvented 
by a centrifugation step between each washing (2 min at 300 × g 
was found to be sufficient). Once fixed using formalin, the cells 
displayed higher adherence and centrifugation was no longer 
necessary (Figure S2B in Supplementary Material). It was thus 
possible to obtain a dense population of cells with minimal 
losses even for immunostaining experiment, requiring multiple 
washing steps. After plating and growth without GM-CSF, MPI 
cells quickly stopped multiplying and a steady number of cells 
could be observed in the plate for up to 1 week (Figure S2C in 
Supplementary Material).
Phagocytic capacity of the MPi cells  
and its stability for live Mtb
We tested the capacity of plated MPI cells obtained after differ-
ent passages to phagocytose live, fluorescent Mtb (H37Rv-GFP). 
This allowed us to compare the phagocytic capacity of low and 
high passage number cells, i.e., obtained below 30 or above 50 
passages, respectively. As shown in Figure  1A and Figure S3 
in Supplementary Material, MPI cells collected after passages 
24 (P24) and 70 (P70) efficiently took up Mtb and displayed 
similar phagocytic patterns, with equivalent ratios of infected 
cells and average amount of bacteria per infected cells observed 
4  h post-infection at all the different MOI tested. The same 
conclusion was drawn for the non-pathogenic mycobacteria 
Mycobacterium smegmatis, against which MPI cells collected 
at P12 and P52 showed a comparable internalization pattern 
(Figure S4 in Supplementary Material). This indicated that the 
capacity of the MPI cells to phagocytose live mycobacteria was 
efficient and stable even after numerous passages. Furthermore, 
we wanted to compare the phagocytic capacity of the MPI cells 
with that of other macrophages routinely used to study Mtb 
infection, namely the Raw 264.7 murine cell line, differentiated 
human THP-1 cells and BMDM. While it was difficult to infect 
exactly the same number of cells from each cell types, a similar 
trend was observed over three independent infection experi-
ments, showing that all cell types had comparable phagocytic 
capacity against Mtb 4 h post-infection. A representative result 
is illustrated in Figure  1B (additional parameters shown in 
Figure S5 in Supplementary Material), obtained with MPI cells 
at P28.
Max Planck Institute cells (P42) were also successfully infected 
as suspended cells under mild shaking (batch infection), as 
shown in Figure 1C. Of note, as batch infections were carried out 
for only 2 h, the ratios of infected cells observed after infections 
were lower than those obtained with plated cells, for an equivalent 
FigUre 1 | Infection patterns of Max Planck Institute (MPI) cells with Mycobacterium tuberculosis (Mtb). Comparison of the phagocytic capacity of MPI cells 
obtained after 24 (P24) or 70 (P70) passages, 4 h post-infection with Mtb. (a) Ratio of infected cells obtained at various multiplicity of infection (MOI). (B) Average 
area of bacteria per infected cells (in pixels). Values are mean ± SD (n = 4) for this representative infection experiment. At each MOI, differences between P24 and 
P70 were found to be non-significant (ns) by two-way ANOVA. (c) Comparison of the phagocytic capacity of MPI cells (P28), THP-1 cells, Raw 264.7, and bone 
marrow-derived macrophages (BMDM). Cells were plated overnight and incubated for 4 h with aliquots of bacterial suspension from the same batch. Values are 
mean ± SD (n = 4) for this representative infection experiment. (D) Kinetics of H37Rv-green fluorescent protein replication in MPI cells (P42) for a representative 
batch infection (100 rpm, 2 h), using different MOI. At each time point, three wells were used for the quantification of the ratio of infected cells using fluorescence 
microscopy. Values are plotted as mean ± SD.
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MOI (Figure  1A). The kinetics of bacterial replication within 
plated MPI cells were followed for 8 days, showing an increasing 
number of GFP positive cells over time (Figure 1D). MPI cells 
were able to withstand low MOIs (1 or below) during this period, 
while MOIs of 10 and above resulted in a near complete destruc-
tion of the cells in less than 3 days.
Mtb-induced cytokine secretion Profiles 
in MPi cells
The cytokine secretion profiles of MPI cells were characterized 
after infection with live or HK Mtb, as well as to LPS stimulation. 
Different MOIs and time points were assessed. Infection of MPI 
cells with HK bacteria (Figure 2A) resulted in the production of 
IL-6 and IL-1α from 24 h post-infection, in a MOI-dependent 
manner, while no IL-10 was detected (detection limit estimated to 
be ~60 pg/mL). Furthermore, HK Mtb also induced secretion of 
tumor necrosis factor alpha (TNF-α) and, in a lesser extent, IL-1β 
in correspondence with previous findings (9), which validates 
the phenotype of the MPI cells used in this study. Infection of 
MPI cells with live Mtb, however, led to a more robust cytokine 
production. As indicated in Figure 2B, there was an increase in 
IL-6, TNF-α, IL-1α, and IL-1β over time, for all MOIs tested. In 
contrast to HK Mtb, the induction of these cytokines started as 
early as 4 h post-infection and increased at 24 h. At a MOI of 
5, the increase in cytokine secretion was sustained up to 48  h 
post-infection (of note, at MOI 10 and 20, the 48 h data point 
was not assessed due to an already advanced destruction of the 
cellular monolayer). Interestingly, higher MOIs did not induced 
stronger responses, indicating that optimal stimulations were 
already achieved at MOI 5. The levels of induced cytokines 
were moderately (IL-6) or dramatically (TNF-α, IL-1α) higher 
than those obtained with HK Mtb or LPS, both being strong 
stimulators of cytokine production in MPI cells (9). Importantly, 
IL-1β was also found in significant amounts in the supernatants, 
particularly at 24 and 48 h post-infection (310 and 590 pg/mL, 
respectively). Surprisingly, MPI cells challenged with live Mtb 
also produced detectable amounts of IL-10 at 24 h post-infection 
(120 and 230 pg/mL at MOI 10 and 20, respectively). A compari-
son between MPI cells and BMDM was also performed (Figure S6 
in Supplementary Material), showing that 8 h after infection with 
live bacteria, MPI cells were secreting more TNF-α, comparable 
FigUre 2 | Continued
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amounts of IL-6 and less IL-1β than BMDM, at all the MOI tested. 
Taken together, these data demonstrate that the MPI cells display 
a distinct and characteristic pro-inflammatory cytokine secretion 
profile in response to Mtb infection.
response to anti-TB Drug Treatment
The prospect of conducting high-throughput screening using 
primary cells is often hampered by the elevated costs needed to 
obtain such cells in sufficient quantities, as well as the need for 
high homogeneity between batches to allow reproducible results. 
To assess the suitability of MPI cells for compound and drug 
screening in the context of TB, we investigated the effects of the 
first line anti-TB agent isoniazid on the intracellular replication 
of Mtb in MPI cells. As shown in Figure 3A, when treated with 
1 µM isoniazid for 5 days, MPI cells displayed strongly reduced 
bacterial loads in their cytoplasm as compared to the control cells 
(1% DMSO). Persistent, presumably live bacteria were still seen 
after treatment, however, indicating the possibility for Mtb to 
survive for an extended period of time within MPI cells despite 
high concentrations of drug in the culture medium. Of note, a 
similar phenomenon is regularly observed with other cells rou-
tinely used in our laboratory for compound testing. Nevertheless, 
FigUre 2 | Kinetics of cytokine secretion in Max Planck Institute (MPI) cells. Production of interleukin 6 (IL-6), TNF-α, IL-1α, IL-1β, and IL-10 by MPI cells (P32)  
in response to (a) heat-killed (HK) Mycobacterium tuberculosis (Mtb) or 10 ng/mL lipopolysaccharide (LPS) or (B) live Mtb infection challenge. Mtb was used at 
different multiplicity of infection (MOI) and cytokines were quantified at 24 h post-treatment for LPS, 4, 8, 24, and 48 h post-infection with HK bacteria and 4, 8,  
24, and 48 h (MOI 5) or 4, 8, and 24 h (MOI 10 and 20) post-infection with live bacteria. Data are representative of three independent experiments and expressed  
as mean ± SD for three biological replicates. Statistical significance between time points (black asterisks) or between stimulated and non-stimulated cells at 
corresponding time points (red asterisks) were determined by Prism software using the unpaired Student’s t-test. *, p-value < 0.05; **, p-value < 0.01; ***, 
p-value < 0.001. nd, not detectable. Nothing was indicated when the differences were found to be non-significant.
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a dose–response effect was observed for isoniazid (Figure 3B), 
with a concentration required to inhibit 50% of the bacterial 
replication (IC50) estimated at 50–80  nM in these conditions. 
A plateau of efficacy was reached for isoniazid above 250–500 nM. 
Consistent IC50 values were measured for isoniazid using other 
cell types, namely Raw 264.7 cells, THP-1 cells, and BMDM 
(Figure 3C). The reproducibility of the IC50 values measured for 
MPI cells over five independent experiments was good (3.9% 
CV), better than that obtained with Raw 264.7 cells (7.6% CV). 
In summary, MPI cells were found to respond very similarly to 
other cell types following isoniazid treatment, both in terms of 
phenotype and measurable drug activity. While not shown here, 
additional dose–responses performed with rifampicin and moxi-
floxacin indicated similar conclusions.
autophagy and Phagosomal acidification
Autophagy is a conserved mechanism allowing cells to degrade 
and recycle intracellular organelles by delivering them to 
lysosomes. Autophagy has also been described as a defense 
mechanism allowing macrophages to eradicate intracellular 
mycobacteria, despite the fact that they normally block the 
phagosome-lysosome fusion process (19–21). To assess the 
capacity of MPI cells to target intracellular pathogenic Mtb into 
autophagosomes, immunostaining experiments were performed 
using antibodies directed against the microtubule-associated 
protein 1A/1B-LC3B, described as a marker of autophagosomes 
(22). In the control condition (1% DMSO), both NI and infected 
MPI cells displayed few LC3B staining (Figures  4A,B), with 
less than 20% of the cells being positive for the immunostain-
ing (Figure S7 in Supplementary Material). This indicated the 
successful escape of the virulent bacteria from autophagosome 
delivery. By contrast, in the presence of 50  µM chloroquine, a 
known inducer of autophagic vacuoles (23), around 90% of the 
cells were found to be positive for LC3B labeling (Figure S7 in 
Supplementary Material). In addition, infected cells displayed a 
strongly reduced bacterial load in their cytoplasm at all MOIs 
FigUre 3 | (a) Treatment of Mycobacterium tuberculosis-infected Max Planck Institute (MPI) cells with the anti-tuberculosis drug isoniazid. Representative pictures 
of MPI cells (P32, blue) treated with dimethyl sulfoxide (DMSO) or isoniazid (INH) for 5 days after batch infection (100 rpm, 2 h) with H37Rv-green fluorescent protein 
(GFP) (green) at a multiplicity of infection (MOI) of 5. Cell nuclei were stained with Hoechst 33342 (blue). Scale bar: 50 µm. Inset from isoniazid treated cells shows 
magnified view of persistent bacterial infection in intact cells. Scale bar: 15 µm. (B) Dose–response of isoniazid against H37Rv-GFP replicating in MPI cells (P18, 
MOI 10). The ratio of infected cells is shown with black, closed circles; the number of cell is shown with gray, open squares. Fitting were performed by Prism 
software using a sigmoidal dose–response model and used to determine the concentration of isoniazid required to inhibit 50% of the bacterial colonization process 
(IC50). Data are mean ± SD for three replicated dose–response. (c) Comparison of isoniazid IC50 values (expressed in log scale) for different cell types. The number 
of infection experiments pooled to build the box plots was 5 for MPI cells and Raw 264.7 cells, 3 for THP-1 cells and bone marrow-derived macrophages (BMDM). 
Box plots are showing the max and min values (brackets), 75th and 25th percentiles (edges of the box), the median value (horizontal bar), and the mean value (+). 
Statistical differences between MPI cells and other cells were determined as non-significant (ns) using a one-way ANOVA with Dunnett’s multiple comparisons test.
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tested (41 px versus 114 px without chloroquine at MOI 20, 
p-value < 0.0001; Figure 4B). This suggested that live, virulent 
bacteria were rapidly eliminated within autophagolysosomes, in 
accordance with previous studies (19).
In a similar fashion, we studied the phagosomal acidification 
process within MPI cells after infection with Mtb. The LysoTracker 
dye was used to follow the appearance of acidic vacuoles in the 
cell cytoplasm following infection with Mtb. NI cells presented 
very few staining (Figure 4C). When infected with live Mtb, a 
slight increase in the number of intracellular acidic vacuoles was 
observed 2 h post-treatment, especially at the lowest MOI tested 
(Figure 4D; Figure S8 in Supplementary Material). This appear-
ance of acidic vacuoles was, however, significantly higher when 
the bacteria were killed by exposure to formalin prior to infec-
tion (66% of positive cells against 21% for live bacteria at MOI 
20, p-value <  0.0001; Figure  4D). This was concomitant with 
a reduction in the number of formalin-killed bacteria detected 
inside the cells (80 px versus 57 px with live bacteria at MOI 20, 
p-value < 0.0005; Figure S8 in Supplementary Material), resulting 
in a low ratio of infected cells but a high amount of LysoTracker 
positive cells and overall LysoTracker area, suggesting the 
successful targeting and destruction of dead bacteria within 
phagolysosomes (Figures  4C,D; Figure S8 in Supplementary 
Material). Taken together, these results show that MPI cells are 
successfully driving formalin-killed bacteria to phagolysosomes 
for degradation, while live Mtb manage to escape this process, 
in accordance with observations previously reported for BMDM 
(24). Of note, the non-primary Raw 264.7 and THP-1 cells are less 
suitable for experiments with LysoTracker, as they usually display 
non-specific background staining without infection (Figure S9 in 
Supplementary Material). This further highlights the relevance 
of the MPI cells as a versatile tool for host-pathogen interactions 
studies in TB.
lipid accumulation
Lipid-loaded macrophages, or foamy macrophages, have an 
increasing significance in TB research given their potency 
to be used as a platform for the study of mycobacterial 
intracellular persistence and reactivation (25). In a recent 
study, a model using VLDL has been described to generate 
FigUre 4 | Light chain 3B (LC3B) positive and acidic vacuoles labeling in Mycobacterium tuberculosis-infected Max Planck Institute (MPI) cells. (a) Representative 
pictures of dimethyl sulfoxide (DMSO) and chloroquine-treated MPI cells (P54, blue), non-infected (NI) and infected with H37Rv-green fluorescent protein (GFP) 
(green) at a multiplicity of infection (MOI) of 10 and labeled with LC3B antibody (red). Scale bar: 15 µm. (B) Comparison of the average area of bacteria per infected 
cells (top) and the average area of LC3B puncta per labeled cells (bottom), between DMSO and chloroquine treated MPI cells infected at different MOI. Values are 
mean ± SD (n = 3). (c) Representative pictures of MPI cells (P38, blue), NI and infected with live or formalin-killed H37Rv-GFP (green) at a MOI of 10 and labeled 
with LysoTracker Deep Red dye (red). Scale bar: 25 µm. (D) Average ratio of infected cells and ratio of LysoTracker positive cells obtained with MPI cells NI or 
infected with live or formalin-killed H37Rv-GFP bacteria. Values are mean ± SD from nine biological replicates. Statistical significance was determined by Prism 
software using two-way ANOVA. ns, non-significant; **, p-value < 0.005; ***, p-value < 0.0005; ****, p-value < 0.0001.
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foamy macrophages in  vitro from BMDM (26). We tested 
whether MPI cells could also be used for this purpose. A 
strong increase in lipid staining was observed for MPI cells 
after treatment with VLDL (58% of cells stained against 7% 
without VLDL treatment, p-value <  0.0001; Figures  5A,B). 
However, the ratio of MPI cells stained after 4  days of incu-
bation was found less prominent than that observed with 
THP-1 cells and BMDM (corrected p-value  <  0.0001). 
FigUre 5 | (a) Lipid droplets accumulation in cells treated with very low-density lipoproteins (VLDL). Representative pictures of naïve and VLDL-treated  
THP-1 cells, Max Planck Institute (MPI) cells (P20), or bone marrow-derived macrophages (BMDM) (blue). The VLDL concentration was adjusted to reach a final 
concentration of 140 µg triacylglycerol (TAG)/mL. Cells were stained with LipidTOX neutral lipid dye (red). Scale bar: 50 µm. (B) Comparison of the ratio of LipidTOX 
stained cells in the presence and absence of VLDL, for different cell types (n = 9). (c) Replication of MPI cells (P26) in the presence of various amounts of VLDL 
(expressed as final concentration of TAG/mL), after 4 days of incubation. Results are mean ± SD from nine biological replicates. Statistical significance compared  
to the non-treated (NT) sample was determined by Prism software using Student’s t-test. *, p-value < 0.05; ***, p-value < 0.0005; ****, p-value < 0.0001.
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We also noticed that the density of MPI at the end of the incu-
bation period was higher than expected, which was confirmed 
by exposure of the MPI cells to increasing doses of VLDL 
(Figure 5C). This indicated that some components within the 
lipoprotein suspension were able to induce the proliferation of 
the cells, an unexpected effect that needs to be considered when 
carrying out such experiments.
DiscUssiOn
In this report, we present the first characterization of the lung 
AM model MPI cells in the context of Mtb infection. Our data 
indicate that these macrophages are well suited for infection 
experiments and can be used as a model to study the process of 
autophagy and phagosomal acidification in Mtb-infected cells. In 
particular, MPI cells displayed the ability to phagocytose Mtb and 
quickly eliminate formalin-killed bacteria through phagosome 
acidification, while live mycobacteria were successfully evading 
this pathway. Together, these data show that MPI cells are com-
petent phagocytes of Mtb and that the mechanisms enabling the 
bacteria to evade destruction and multiply inside the phagosomes 
are functional in these cells.
Max Planck Institute cells have the capacity to grow as both 
attached and free-floating cells. While difficult to quantify, it 
also appears clearly throughout our experiments that the MPI 
cells had the tendency to aggregate and form clumps after Mtb 
infection, as visible in Figure 3A for the DMSO-treated cells. This 
might be linked with the active movement of these cells, able to 
detach and reattach, similarly to the functions of AMs in the res-
piratory system (5). This mobility may also have an importance 
for the granulomatous response observed in the lung during Mtb 
infection (2).
Pro-inflammatory cytokines play crucial roles in the control 
of Mtb infection. IL-6 and TNF-α play important roles in the 
pathogenesis of TB, while IL-1α and IL-1β have been described as 
essential elements of the immune response against Mtb infection 
in vivo, able to coordinate the host defense for effective bacterial 
containment within the granuloma (27). In humans, decreased 
IL-1α in plasma has been correlated with active TB in contrast 
to patients with asymptomatic TB, indicating the importance of 
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IL-1α in the control of Mtb infection and the relevance of this 
cytokine as a potential target for host-directed therapy (28). 
Furthermore, cells obtained by bronchoalveolar lavage from TB 
patients showed a strong spontaneous release of IL-1β, as well as 
IL-6 and TNF-α, mostly driven by AMs (29).
The anti-inflammatory cytokine IL-10 can decrease the host’s 
control over Mtb by impairing phagosome maturation and reduc-
ing the production of reactive oxygen species (30, 31). The nega-
tive influence of IL-10 on anti-mycobacterial defenses has been 
demonstrated in IL-10 deficient mice, for which Mtb infection 
resulted in a reduced bacterial load in vivo (32). The evaluation 
of the cytokine secretion profile of MPI cells after Mtb infection 
indicated a highly pro-inflammatory response, including a very 
strong secretion of IL-6, TNF-α, and IL-1α, as well as significant 
amounts of IL-1β. The innate response to live Mtb is induced 
partly via sensing of cell components of incoming mycobacterial 
particles via TLR2, TLR9, the C-type Lectin Receptors Mincle and 
Dectin-1, the scavenger receptor MARCO, and the cytoplasmic 
receptor NOD2 during the early phases of mycobacterial infection, 
while subsequent mycobacterial replication inside macrophages 
generates further cytokine production (33–35). Using HK Mtb 
particles, we previously observed the potent production of IL-6 
and IL-1α induction but a lack of IL-10 induction in MPI cells (9, 
10), findings that were also verified in this study. Furthermore, we 
demonstrate here the efficient production of TNF-α and the weak 
induction of IL-1β in HK Mtb-stimulated MPI cells. By contrast, 
infection of MPI cells with live mycobacteria resulted in a more 
potent induction of the pro-inflammatory cytokines tested. 
Using the same or a lower MOI of live compared to HK Mtb, we 
observed significantly higher levels of TNF-α, IL-1α, and IL-1β. 
In addition, all three cytokines were produced at earlier time 
points post-infection. Thus, our present data indicate that live 
Mtb induces a higher production of pro-inflammatory cytokines 
in MPI cells as compared to HK bacteria, probably because of its 
intracellular replication.
Acting on the same receptor, both IL-1α and IL-1β play crucial 
roles in anti-mycobacterial defense. Interestingly, we found more 
IL-1α secretion (up to 100 ng/mL 48 h post-infection) than IL-1β 
(590  pg/mL at the same time point, Figure  2). Mycobacterial 
gene expression modifies host macrophage responses through a 
functional ESX-1 secretion system, suppressing inflammasome 
activation and consequent IL-1β responses to virulent strains, 
while inflammasome activation may not be required for IL-1α 
secretion (9, 35, 36). This could explain the lower induction levels 
of IL-1β and emphasize the importance of a potent, Mtb-triggered 
IL-1α production in macrophages. Interestingly and in contrast 
to LPS and HK Mtb stimuli, challenge with live mycobacteria led 
to a delayed but efficient production of IL-10 in MPI cells. Since 
AMs are the primary targets of Mtb, the observed production of 
this anti-inflammatory cytokine is likely to be advantageous for 
this pathogen. Therefore, it is likely that Mtb developed mecha-
nisms enabling the induction of IL-10. Nevertheless, further work 
is necessary to clarify the molecular details of Mtb-induced IL-10 
and IL-1α secretion mechanisms of AMs and MPI cells.
Together, our results demonstrate that the MPI cell system 
represents a physiologically relevant model of Mtb-induced 
innate responses. This can be of primary importance for the study 
of the induction of both pro- and anti-inflammatory cytokines in 
TB, as well as for the establishment of functional host-directed 
therapies targeting the pathways induced by these cytokines. 
MPI cells also offer the possibility to study Mtb pathogenesis in 
a relevant, primary AM model. As MPI cells are continuously 
growing cells, which are easy to obtain in large quantities, the 
delineation of relevant cellular mechanisms of Mtb pathogenesis 
can be done using this system.
Other experiments are ongoing to further investigate the inter-
actions between Mtb and this new model of host macrophages. 
In particular, a comparison of the transcriptional respon ses 
of BMDM, MPI cells, and AMs in response to Mtb infection 
will be conducted, as well as an investigation of the recognition 
and phagocytosis mechanisms. MPI cells can be efficiently 
trans fected and gene knockout MPI cell lines relevant for Mtb 
pathogenesis can be made (9, 10), allowing genetic studies to be 
conducted using these cells and paving the way toward a better 
understanding of AM functions in TB pathogenesis. What is 
already clear based on the results we provide here is that having 
such self-renewable, primary cells at disposal is a strong benefit 
for experiments where primary cells are required. Indeed, the 
need for animal sacrifice to recover or generate macrophages is 
greatly reduced, as all the preliminary testing and optimization 
of experiments with AMs can be done using the MPI cells. While 
more remains to be done, this work highlights the usefulness of 
these innovative macrophages in TB research as well as in the 
more widespread field of lung diseases.
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